● Recruiting

Clinical Study of Rituximab for the Treatment for Idiopathic Membranous Nephropathy with Nephrotic Syndrome

Condition: Glomerulonephritis, Membranous · Nephrotic Syndrome，Idiopathic · Sponsor: Shoichi Maruyama MD PhD

PhasePhase 3

Planned participants88

Who can joinAll sexes, 15 Years to no upper limit

Healthy volunteersNo

About this study

To confirm the efficacy and safety of rituximab (genetical recombination) intravenously administered to idiopathic membranous nephropathy with nephrotic syndrome.

This description comes directly from the study's public registry record.

Talk to the study team

Shoichi Maruyama, PhD, MD · +81527442192 · marus@med.nagoya-u.ac.jp

Shinobu Shimizu, PhD · +81527442942 · shimizu.shinobu.w3@f.mail.nagoya-u.ac.jp

Always discuss trial participation with your own doctor first.

Locations (18)

Anjo Kosei Hospital	Anjo, Aichi-ken, Japan	Recruiting
Kasugai Municipal Hospital	Kasugai, Aichi-ken, Japan	Recruiting
Konan Kosei Hospital	Kōnan, Aichi-ken, Japan	Recruiting
Nagoya University Hospital	Nagoya, Aichi-ken, Japan	Recruiting
Fujita Health University hospital	Toyoake, Aichi-ken, Japan	Recruiting
Juntendo University Urayasu Hospital	Urayasu, Chiba, Japan	Recruiting
Kyushu University Hospital	Fukuoka, Fukuoka, Japan	Recruiting
Kurume University Hospial	Kurume, Fukuoka, Japan	Recruiting
Asahikawa Medical University Hospital	Asahikawa, Hokkaido, Japan	Recruiting
Kanazawa University Hospital	Kanazawa, Ishikawa-ken, Japan	Recruiting
Kumamoto University Hospital	Kumamoto, Kumamoto, Japan	Recruiting
University Hospital,Kyoto Prefectural University of Medicine	Kyoto, Kyoto, Japan	Recruiting

+ 6 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05914155